Shawn A. Scranton
Präsident bei Amber Ophthalmics
Aktive Positionen von Shawn A. Scranton
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Amber Ophthalmics
Amber Ophthalmics BiotechnologyHealth Technology Amber Ophthalmics is a clinical-stage biotechnology company that focuses on ophthalmology. The company is based in San Diego, CA. The company has developed a patent-protected, first-in-class unmodified antisense oligonucleotide that inhibits a cell membrane hemichannel forming protein called connexin43 (cx43). | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Präsident | - | - |
Karriereverlauf von Shawn A. Scranton
Ehemalige bekannte Positionen von Shawn A. Scranton
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PFENEX INC. | Geschäftsführer | 01.10.2018 | 01.10.2020 |
Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sentynl Therapeutics, Inc. acquires, develops and commercializes prescription products. The company was founded by Matthew Heck and is headquartered in Solana Beach, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.01.2017 |
Victory Pharma, Inc.
Victory Pharma, Inc. Pharmaceuticals: MajorHealth Technology Victory Pharma, Inc. was a specialty pharmaceutical company that acquired markets and developed prescription pharmaceutical products that treat pain and related conditions. It marketed these products to health care professionals through its experienced U.S. commercial organization. The company was founded in 2003 and was headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | 02.01.2012 |
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Corporate Officer/Principal | 01.01.2005 | 02.01.2007 |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | 01.01.2001 | 02.01.2005 |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Corporate Officer/Principal | 01.01.1998 | 02.01.2000 |
Baylor College of Medicine | Corporate Officer/Principal | - | - |
Ausbildung von Shawn A. Scranton
University of California San Diego | Undergraduate Degree |
University of the Pacific | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Victory Pharma, Inc.
Victory Pharma, Inc. Pharmaceuticals: MajorHealth Technology Victory Pharma, Inc. was a specialty pharmaceutical company that acquired markets and developed prescription pharmaceutical products that treat pain and related conditions. It marketed these products to health care professionals through its experienced U.S. commercial organization. The company was founded in 2003 and was headquartered in San Diego, CA. | Health Technology |
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sentynl Therapeutics, Inc. acquires, develops and commercializes prescription products. The company was founded by Matthew Heck and is headquartered in Solana Beach, CA. | Health Technology |
Amber Ophthalmics
Amber Ophthalmics BiotechnologyHealth Technology Amber Ophthalmics is a clinical-stage biotechnology company that focuses on ophthalmology. The company is based in San Diego, CA. The company has developed a patent-protected, first-in-class unmodified antisense oligonucleotide that inhibits a cell membrane hemichannel forming protein called connexin43 (cx43). | Health Technology |
- Börse
- Insiders
- Shawn A. Scranton
- Erfahrung